Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sander Ellegård"'
Autor:
Sander Ellegård, Kristina Engvall, Mustafa Asowed, Anna-Lotta Hallbeck, Nils Elander, Olle Stål
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionSince its introduction in standard of care, trastuzumab has revolutionized the treatment of patients with early and late stages of HER2-positive breast cancer. While the initial clinical trials were convincing and lead to major changes in
Externí odkaz:
https://doaj.org/article/b14f3d05c80248c9b2c9ce859278c793
Autor:
Linda Bojmar, Elin Karlsson, Sander Ellegård, Hans Olsson, Bergthor Björnsson, Olof Hallböök, Marie Larsson, Olle Stål, Per Sandström
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e84815 (2013)
The role of the epithelial-mesenchymal transition (EMT) in cancer has been studied extensively in vitro, but involvement of the EMT in tumorigenesis in vivo is largely unknown. We investigated the potential of microRNAs as clinical markers and analyz
Externí odkaz:
https://doaj.org/article/948f798d166f4287b0a5cc84129eaa12
Publikováno v:
Cancer Research. 79:P2-13
Background: The prognosis for patients with HER2-positive early breast cancer (EBC) has improved dramatically since the introduction of adjuvant trastuzumab therapy. With the addition of pertuzumab the prognosis has improved further. However, there i
Autor:
Anna-Lotta Hallbeck, Sander Ellegård, Olle Stål, Nils O. Elander, Cynthia Veenstra, Giseh Pérez-Tenorio
Publikováno v:
The Breast. 36:S46
Autor:
Sander Ellegård, Marie Larsson, Olle Stål, Per Sandström, Olof Hallböök, Elin Karlsson, Bergthor Björnsson, Linda Bojmar, Hans Olsson
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 12, p e84815 (2013)
PLoS ONE, Vol 8, Iss 12, p e84815 (2013)
The role of the epithelial-mesenchymal transition (EMT) in cancer has been studied extensively in vitro, but involvement of the EMT in tumorigenesis in vivo is largely unknown. We investigated the potential of microRNAs as clinical markers and analyz
Publikováno v:
Cancer Research. 72:451-451
The majority of all cancer deaths are caused by metastases rather than the primary tumour. The process by which cells can develop migratory properties is suggested to occur through an epithelial-mesenchymal transition (EMT). The microRNA (miR) 200 fa